Scotland · NHS Scotland MSAN
Zanamivir (Dectova®) 200mg/20ml solution for infusion vials
MSAN(2025)3 · Level 3 · issued 16 Jan 2025
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| 1. Zanamivir (Dectova®) 200mg/20ml solution for infusion vials are in limited supply until late | Limited supply | late |
| 3. Zanamivir (Relenza®) 5mg inhalation powder blisters with device remain available and can | Available | — |
| 4. All strengths and formulations of oseltamivir remain available. | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
Provenance
Where this record's bytes came from and when they entered the record. The same fields ship with every API record (/api), so a citation can be checked against the capture. Internet-Archive recoveries are dated by the Archive's capture, never ours.
scot:msan:2025:3
- Recorded
- 13 Aug 2026 22:03 UTC
- Capture route
- Captured first-hand by ShortageSignal's scheduled check
- Read from
- NHS Scotland Medicine Supply Alert Notice (PDF)
- Captured at
- 13 Aug 2026 22:03 UTC
- Content hash
4670213afdf77f6df12b868f2f3a345bad5109f5b5b169f40209b586c71499f0sha256 of the captured bytes — proves what was captured, not that the source was correct- Source document
- https://www.publications.scot.nhs.uk/files/msan-2025-03.pdf ↗
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.